<DOC>
	<DOCNO>NCT00005017</DOCNO>
	<brief_summary>The purpose study see effective safe give 1 3 follow treatment patient may receive anti-HIV treatment : 1 ) lamivudine ( 3TC ) /abacavir ( ABC ) /stavudine ( d4T ) ; 2 ) 3TC/ABC/efavirenz ( EFV ) ; 3 ) 3TC/ABC/amprenavir ( APV ) /ritonavir ( RTV ) .</brief_summary>
	<brief_title>Effectiveness Safety Epivir/Ziagen/Zerit ( 3TC/ABC/d4T ) Versus Epivir/Ziagen/Sustiva ( 3TC/ABC/EFV ) Versus Epivir/Ziagen/Agenerase/Norvir ( 3TC/ABC/APV/RTV ) HIV Patients Who Have Never Received Treatment</brief_title>
	<detailed_description>Patients randomize initiate antiretroviral therapy 1 3 treatment group . Within group stratify base HIV-1 plasma RNA level . Group 1 : Patients receive 3TC/ABC/d4T ; Group 2 : Patients receive 3TC/ABC/EFV ; Group 3 : Patients receive 3TC/ABC/APV/RTV . Treatment continue 96 week . Blood sample collect measure plasma HIV RNA CD4 count patient assess regularly . In event incomplete viral suppression virologic failure , patient switch secondary therapy .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Amprenavir</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible trial : Are HIVpositive . Are least 18 year old . Have viral load least 5,000 copies/ml . Have CD4 count least 50 cells/mm3 . Agree practice effective method birth control study , woman . Patients eligible trial : Are pregnant breastfeeding . Have ever take antiHIV drug . ( Less 2 week prior antiHIV treatment allow . ) Have history AIDSdefining opportunistic illness ( except Kaposi 's sarcoma involve skin ) within 45 day screen visit . Treatment illness must complete least 30 day prior screen . Are enrol another study medication may interfere control viral load study . Have serious medical condition diabetes heart problem would make unsafe study . Have history severe nerve disease type may cause muscle weakness . Have pancreatitis ( inflamed pancreas ) hepatitis within 6 month start study . Have radiation treatment chemotherapy within 4 week prior study entry , think treatment may need study period . Local treatment Kaposi 's sarcoma allow . Have use certain medication , include vaccine , interfere immune system within 4 week prior study entry . Have take HIV vaccine within 3 month prior entry . Are take St. John 's wort . Have history allergic study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2001</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Stavudine</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>VX 478</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>abacavir</keyword>
	<keyword>efavirenz</keyword>
</DOC>